ERβ as a mediator of estrogen signaling in inflammatory breast cancer
A new editorial paper titled "ERβ as a mediator of estrogen signaling in inflammatory breast cancer" has been published in Oncotarget.
Jul 3, 2023
0
1
A new editorial paper titled "ERβ as a mediator of estrogen signaling in inflammatory breast cancer" has been published in Oncotarget.
Jul 3, 2023
0
1
An accurate tool that is readily available could be used to predict whether frail patients are likely to survive intensive cancer treatments such as chemotherapy, according to researchers from the University of Surrey.
Jun 26, 2023
0
0
Researchers have found that nanotechnology can increase chemotherapy's effectiveness. The new research could be good news for people who develop peritoneal cancer in the future.
Jun 20, 2023
0
47
Together, the McGill University Health Centre (MUHC), the Centre hospitalier de l'Université de Montréal (CHUM) and St. Mary's Hospital Center (SMHC) have contributed to an international clinical trial that will change ...
Jun 20, 2023
0
43
Oncologists have traditionally prescribed androgen deprivation therapy (ADT) alone for patients with metastatic hormone-sensitive prostate cancer (mHSPC).
Jun 9, 2023
0
9
The American Society for Radiation Oncology (ASTRO) Gastrointestinal Cancers Resource Panel issued the following statement today regarding the PROSPECT clinical trial for patients with rectal cancer:
Jun 7, 2023
0
29
A new research paper was published in Oncotarget, titled "Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC)."
Jun 7, 2023
0
2
Doctors and hospitals across the country are scrambling to make every drop of chemotherapy and other prescription drugs count, given the national shortage in medicines used to treat cancer and a multitude of conditions.
Jun 6, 2023
0
2
An experimental targeted therapy can dramatically slow the progress of common slow-growing brain cancers, a new clinical trial finds.
Jun 5, 2023
0
76
For women with persistent, recurrent, or metastatic cervical cancer, adding pembrolizumab to chemotherapy, with or without bevacizumab, is associated with improved overall and progression-free survival, according to a study ...
Jun 2, 2023
0
5